SynthesisDrug design, development and therapy2019

Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis.

Qing Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.